Joint symptoms associated with anastrozole and letrozole in patients with breast cancer: a retrospective comparative study.

about

Joint symptoms associated with anastrozole and letrozole in patients with breast cancer: a retrospective comparative study.

Item

http://www.wikidata.org/entity/Q47119155

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Joint symptoms associated with ...... trospective comparative study.

@en

Joint symptoms associated with ...... trospective comparative study.

@nl

type

Item

label

Joint symptoms associated with ...... trospective comparative study.

@en

Joint symptoms associated with ...... trospective comparative study.

@nl

prefLabel

Joint symptoms associated with ...... trospective comparative study.

@en

Joint symptoms associated with ...... trospective comparative study.

@nl

P1476

Joint symptoms associated with ...... etrospective comparative study

@en

P2093

Chiho Tsuruta

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Watanabe

http://www.w3.org/2001/XMLSchema#string

Shuhei Sarumaru

http://www.w3.org/2001/XMLSchema#string

Yuko Oshima

http://www.w3.org/2001/XMLSchema#string

P2860

Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.

The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia.

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole--of clinical importance?

Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.

Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole.

Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.

Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.

Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozole.

P2888

s40780-017-0095-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40780-017-0095-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yoshihito Morimoto

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092584522

http://www.w3.org/2001/XMLSchema#string

P698

29177067

http://www.w3.org/2001/XMLSchema#string

P932

5688801

http://www.w3.org/2001/XMLSchema#string